Objective: To determine clinical pattern, prevalence, and factors associated with pediatric immune reconstitution inflammatory syndrome (IRIS) in Uganda.
Introduction
With antiretroviral therapy (ART), there has been a significant decline in AIDS-associated morbidity and mortality [1] [2] [3] . However, between 5 and 45% of adults who start ART experience clinical deterioration as the immune system recovers [1, 2, 4] . This paradox is referred to as the immune reconstitution inflammatory syndrome (IRIS). Two distinct clinical scenarios of IRIS occur. 'Paradoxical IRIS' is the clinical recrudescence of a previous successfully treated opportunistic infection. The symptoms of paradoxical IRIS can be quite similar to the initial infection, potentially leading to clinical misclassification as an opportunistic infection relapse and immunologic ART failure. The second scenario, 'unmasking IRIS', is the immunologic unmasking of subclinical infections after ART initiation and is characterized by the rapid development of new opportunistic infection's with accelerated, atypical, or exaggerated symptoms. Distinguishing unmasking IRIS from clinical deterioration due to ongoing immunodeficiency is ill defined and controversial [5] .
The incidence of IRIS is highly dependent on the population studied, specifically with the degree of immunosuppression and the opportunistic infection burden [6] . Unlike adults, little is known about the magnitude of IRIS in children [7, 8] . Prospective Thai studies [8, 9] reported a pediatric IRIS incidence of 19%, but it was increasingly becoming common in children. Whether these results are generalizable to sub-Saharan Africa is unknown. In Africa, the majority of HIVinfected children present late to healthcare after they are severely immunosuppressed and infected with opportunistic infection. These factors likely may increase the risk of IRIS [9] [10] [11] . In South Africa, nearly 10% of children die within 6 months of initiating ART, and in Uganda, 40% of children are hospitalized within the first 6 weeks of ART with 74% of the deaths occurring within 6 months of starting ART [12, 13] . With the global ART roll out, there is a need for more information on IRIS in resource-limited settings. We sought to determine the prevalence, clinical epidemiology, and risk factors associated with IRIS in HIV-infected children having newly initiated ART in Uganda.
Methods

Setting and design
The multicenter, prospective cross-sectional study was conducted between December 2006 and October 2007 at three Joint Clinical Research Centre (JCRC) clinics located in three regions in Uganda. JCRC had 52 satellite clinics and attached 25 outreaches in all regions of Uganda and provided ART to more than 40 000 adults and children in 2008. Participants were recruited consecutively from Kampala, Mbale, and Fort Portal sites located in the central, eastern, and western regions of Uganda, respectively.
Study population
Consecutive patients aged below 18 years presented to the clinics were screened for enrollment. Inclusion criteria were children receiving ART between 2 and 24 weeks and whose caregivers provided informed consent. Assent was sought for adolescents above 14 years of age. Exclusion criteria were those with preexisting liver or kidney insufficiency (>5Â above normal) or ART nonadherence (<95% adherence by self-report). The study was approved by the Makerere University Faculty of Medicine and Uganda National Council of Science and Technology.
Study procedures
A physician based at each site consecutively screened and enrolled patients. Enrolled patients were evaluated with a detailed history and physical examination documented using a standardized questionnaire. A history of contact with an adult with chronic cough or with tuberculosis (TB) was captured. Laboratory investigations included complete blood count, Giemsa-stained blood smear for malaria, liver and renal function tests, T-cell profile, HIV viral load, C-reactive protein, erythrocyte sedimentation rate, and tuberculin skin test (TST). Past medical records of enrolled patients were reviewed. Data on previous diagnosis of opportunistic infections and baseline laboratory values were recorded. As this was a crosssectional study, evaluation for IRIS events only occurred at time of the study visit.
Immune reconstitution inflammatory syndrome case definition
A case of IRIS was defined as a clinical situation in which a research participant fulfilled at least one major clinical criterion with a decrease of viral load of at least 1 1og 10 or at least one major clinical criterion with at least two minor criteria according to an adopted IRIS diagnostic criteria from a French study [14] . In this pediatric population with a frequent inability to produce an expectorated sputum, the diagnosis of TB was primarily made on clinical history (cough >2 weeks, weight loss, anorexia, fever, and contact with an adult with TB), physical examination, chest radiograph, and TST. All children then received anti-TB therapy, and as per the IRIS clinical case definition were required to have a clinical response. Thus, although the strength of the TB diagnoses is considered at best as possible/probable TB, the clinical pattern of improvement with anti-TB therapy followed by clinical deterioration after ART initiation is very compatible with probable paradoxical TB-IRIS.
Immunological and viral success
Immunological success was defined as an increase from pre-ART in CD4 þ T-cell percentage of at least 15% and viral success was achieving a HIV viral load of below 50 copies/ml.
Data analysis
Data were entered using EPI-DATA 2.1b (Centers for Disease Control and Prevention, Atlanta, Georgia, USA) and analyzed with SPSS 12.0 (SPSS Inc., Chicago, Illinois, USA). Comparisons were made between patients with IRIS and controls without IRIS from clinical and laboratory data collected at the study visit. Univariate analysis was performed and categorical variables were summarized as frequencies and analyzed using the x 2 test.
Continuous variables were expressed as means, median, and SD, analyzed using Student's t-test and displayed using tables and figures.
Bivariate analysis with IRIS as the outcome to determine associations was done. Statistical significance was determined at two-sided P value of less than 0.05. A multivariate analysis using forward stepwise logistic regression was used to control for confounders to determine adjusted odds ratio (OR). All potential correlates were entered into the model, and the variables that did not retain significance (P < 0.05) were eliminated.
Results
Sample characteristics
Of 414 children screened, 263 (64%) fulfilled the inclusion criteria, of whom 162 (62%) were consented and included in the analysis ( Fig. 1 ). Of the 162 children studied, 57.4% (93/162) were female. The age range was 0.5-18 years with a median age of 6 years [interquartile range (IQR) 2.5-11 years]. At initiation of ART, using the WHO classification system, 73% of enrolled children were of stage III/IV status (Table 1 ). At the time of ART initiation, none of the study patients had clinically active opportunistic infections, and all patients were receiving trimethoprim-sulfamethoxazole prophylaxis. At time of the study interview, the median time on ART was 11.5 weeks (IQR 3.5-20 weeks). No ART interruptions occurred according to self-report and clinic-based pill counts.
Prevalence of immune reconstitution inflammatory syndrome
The overall prevalence of IRIS was 38% at the study visit. The prevalence of IRIS in male children was higher than in female children, that is, 48 vs. 31% (OR 2.02, 95% CI 1.06-3.86, P ¼ 0.023). Unmasking IRIS events accounted for 77% of the episodes compared with 23% of the paradoxical IRIS events. The prevalence of IRIS was found to be highest in the 5-12-year-old age group with a median age of 6.75 years. The prevalence of IRIS was highest in the first month of ART, followed by the next 3 months period, and least in the 3-6 months of ART.
Clinical pattern of immune reconstitution inflammatory syndrome
The clinical presentation of patients with IRIS is shown in Table 2 . TB was the most common IRIS presentation accounting for 25 (29%) of the patients with a prevalence of 15.4% (25/162). Of mycobacterial-IRIS, 20 (80%) had pulmonary TB, two had disseminated TB, and three had Bacille-Calmette-Guerin (BCG) lymphadenitis (BCG-IRIS). Fourteen patients (8.6% prevalence) had no prior TB diagnosis and were considered ARTassociated TB (i.e. unmasking TB-IRIS). Paradoxical TB-IRIS occurred in 11 children who had a prior TB diagnosis with an overall prevalence of 6.8%.
The other presentations were worsening or recurrence of pruritic papular eruption and extensive oral candidiasis (seven, 7.5%), acute bacterial pneumonia (six, 6.5%), verruca planus (four, 6.5%), and taenia skin manifestations (four, 4.3%) with extensive involvement of the face, hair, 
Preantiretroviral therapy laboratory parameters
The majority (70%) of study participants were severely immunosuppressed with a CD4 þ cell percentage of 15 or less and these children were more likely to develop IRIS (OR ¼ 1.00, 95% CI 1.07-4.82, P ¼ 0.033) when compared with those with a CD4 þ cell percentage of at least 15 at ART initiation ( Data are % (n). Opportunistic infections were verified by pharmacy prescription records. ART, antiretroviral therapy; CI, confidence interval; IRIS, immune reconstitution inflammatory syndrome; OR, odds ratio. baseline were more likely to have IRIS (OR ¼ 3.30, 95% CI 1.40-7.78, P ¼ 0.005) ( Table 4 ). HIV-1 viral loads were decreased from baseline with a median of 501 HIV RNA copies per milliliter (range <40-7 800 000 copies/ ml) at the study visit. Of the 82 children who had viral loads measured, only four achieved undetectable plasma viral suppression (<40 copies/ml) at a median time on ART of 11.5 weeks.
Risk factors associated with immune reconstitution inflammatory syndrome
On multivariate analysis, the factors independently associated with IRIS were male sex, pre-ART CD4 þ cell percentage of less than 15, study visit CD8 þ cell absolute count below 1000 cells/ml, and cough at study visit ( Table 5 ).
Discussion
Despite numerous descriptions of the infectious and noninfectious causes of IRIS, the overall incidence remains largely unknown, particularly in many resourcelimited areas and pediatric populations. There is no consensus on case definitions for IRIS in children, yet we continue to recognize probable IRIS-like presentations. We report a cross-sectional prevalence of IRIS of 38% during the first 6 months of ART in Uganda. The majority of these events (77%) would be considered unmasking IRIS manifestations. The vast majority of these events were atypical in having exaggerated clinical presentations, although the contribution of ongoing immunosuppression cannot be discounted. The overall, very important implication is that pediatric HIV care consists much more than simply delivering antiretroviral medications to children and that in the first few months of ART, subclinical infections are frequently unmasked. This should be an expectation for patients, their caregivers, healthcare workers, and policy makers.
The ability of comparison of this cross-sectional study with other cohorts is limited, as the majority of studies have been retrospective in design, focused on adults, or both, with a few exceptions [9] . The prevalence of IRIS in this sub-Saharan African cohort appeared to be higher than the 23.4% IRIS prevalence in hospitalized Thai children [9] . Another retrospective pediatric cohort study [15] reported an IRIS incidence of 20% among 91 children in Lima, Peru. Retrospective design has some limitations with incomplete documentation, leading to misclassification of such a relatively new entity as IRIS.
Our study does match up similarly to the 41% incidence of probable and possible IRIS prospectively observed in a large adult cohort in Durban, South Africa [16] .
The high prevalence of IRIS in this study population is possibly attributed to late presentation and a high background burden of subclinical infections. Diagnosis of HIV infection in infants is complicated, and in resourcelimited areas often delayed, due to lack of diagnostic resources and lack of parental awareness of their own HIV status and thereby the infant's risk. The result is continued late presentation of HIV-infected children seeking HIV care only after developing advanced immunosuppression and presenting with one or more opportunistic infections. This is reflected in this study population, as the majority (70%) started ART with baseline CD4 þ cell percentage below 15, indicative of severe immunosuppression and at risk of opportunistic infections. Second, in this resourcelimited environment, children are frequently exposed to high background of infectious disease from opportunistic infections, environmental, and childhood vaccinepreventable diseases. In the absence of comprehensive pre-ART screening, subclinical infections are likely frequently present when starting ART.
In this study, the peak time of IRIS occurrence was within the first month of commencing ART. In the study by Shelburne et al. [9] , most IRIS events presented in the first 60 days after ART initiation and in the Bakeera-Kitaka et al. study [10] , the median time of occurrence of TB-IRIS was at 14 weeks. The probable reason why IRIS may occur earlier in children than adults is two-fold. First, children have a more robust improvement of their immune system with ART than adults, specifically children often achieve a 10-fold CD4 þ T-cell increase, mainly of naive T cells [17] . In our study, a rise of at least 25 CD4 þ cells per microliter from baseline carried a three-fold risk of having an IRIS event, and the CD4 cell count increase was most marked in the first month on ART when most IRIS events occurred. Our analysis did not adjust for time on ART. Thus, even though IRIS patients had a shorter duration of ART than controls without IRIS, the CD4 response was more robust in IRIS patients. Demographic factors also were associated with IRIS for both clear and unclear reasons. Increasing age was associated with IRIS, peaking in children who were 5-12 years of age. Age correlated with the degree of immunosuppression, thus on multivariate analysis, age was not an independent risk factor. Increasing age also represents increasing time at risk of TB exposure. Older children also had easier clinical history taking, making it easier to diagnose IRIS-related events. Sex was also associated with IRIS. In our study, the prevalence of IRIS in male children was higher and remained so in multivariate analysis. This is similar to that observed in the study by Shelburne et al. [9] who reported a 2.65-fold risk in males for IRIS, yet differs from other prospective adult cohorts in Africa [18, 19] . The biological plausibility of sex as a risk factor for IRIS in children is unknown.
IRIS can manifest with a wide variety of clinical symptoms, depending on the target of the inflammatory response, thus the resulting clinical manifestation of IRIS depends on the prevailing infections in the locality. In our study, multiple and varied presentations of IRIS occurred. There were 86 clinical episodes of IRIS characterized as 18 distinct clinical scenarios, which occurred in 62 children. The clinical scenarios involved either unusual manifestations of a previously treated opportunistic infection or unmasking of a previously subclinical infection [1, 16, [19] [20] [21] [22] .
Mycobacterial-immune reconstitution inflammatory syndrome
Considering that Uganda is a high TB burden country, it was not surprising that unmasking TB-IRIS was the most common single clinical scenario of IRIS. The proportion of TB-IRIS events (29%) was similar to the proportion of mycobacterial-related IRIS observed in Thailand (44%) and Peru (35%) [8, 15] . In adult studies, paradoxical TB-IRIS manifestations primarily occur within the first 3 months of ART and have been reported as fever, lymphadenitis, subcutaneous abscesses, pulmonary infiltrates, or inflammatory masses [22] . In our pediatric cohort, the most common symptoms of TB-IRIS were fever, cough, and lymphadenopathy. The 15% overall incidence of ART-associated TB in this study was similar to adult studies [11, [23] [24] [25] , and similar to the 17% incidence previously reported by Bakeera-Kitaka et al. [10] from Kampala, Uganda, and higher than the 9% incidence reported in Chiang Mai, Thailand and 6.5% in Peru [9, 15] . The higher prevalence of unmasking ARTassociated TB in Uganda than in Thailand or Peru may reflect the increased burden of TB in sub-Saharan Africa.
Our finding that cough for more than 7 days at the time of enrollment was associated with IRIS is not surprising, as TB was the most common clinical infection. Uganda is in the top 15 TB burden countries globally with a high incidence of HIV-TB coinfection. Children are con-tinually exposed to adults with TB, and those family members are also HIV infected.
Of the 25 children with mycobacterial-IRIS, three (2.1%) had clinical BCG-IRIS with ipsilateral lymphadenopathy with ulceration or abscess formation at the site of the BCG scar at time of the study visit. This has also been described in a South African pediatric cohort of children below 24 months with a higher 11.2% prevalence of BCG-IRIS [26] . In restricting our cohort to children below 12 months, the prevalence of BCG-IRIS was 19% at time of the study visit. The overall incidence may have been higher.
Dermatologic immune reconstitution inflammatory syndrome
Little information exists on how ARTaffects the course of dermatologic conditions in children, whereas in adults, dermatological manifestations of IRIS appear to be the most frequent [16, 19, 27] . This study has demonstrated that dermatological manifestations were the most common IRIS events. Some of the types of dermatologic events such as paradoxical Kaposi sarcoma, molluscum contagiosum, and varicella zoster have been reported in adults [7, 18] .
Other manifestations were considered as unmasking IRIS events due to their unusual, exaggerated presentation. For example, three otitis media episodes presented with exaggerated purulent discharge in conjunction with immunologic success and viral suppression.
This vast clinical manifestation of IRIS depends on the prevailing infections in the locality of HIV care. Our study was interested in all manifestations of IRIS, thus the diverse presentations observed. In resource-limited areas where screening for opportunistic infections is primarily clinical, unmasking of subclinical opportunistic infections appears to be common.
Factors associated with immune reconstitution inflammatory syndrome
We neither find the type of ART regimen, pre-ART hemoglobin level, CD4 þ : CD8 þ ratio, previous opportunistic infection, WHO stage III and IV, a shorter interval between initiating treatment for opportunistic infection, and starting ART, nor a rapid viral load decline to be associated with IRIS, as has been described in other adult cohorts [6, 27] .
The absolute CD8 þ cells count at interview below 1000 cells/ml was associated with a four-fold risk of IRIS development. In a US study [28] of 120 adolescents, decreased CD8 þ cell count was associated with a temporary clinical deterioration while on ART. In our population having a low CD8 þ T-cell count correlated with older age.
Limitations
There is no validated pediatric IRIS case definition to date, and this creates a challenge in diagnosing IRIS. This study used a prospective case definition in conjunction with expert opinion, similar to other recent studies [16, 29] . Additionally, what is and is not 'IRIS' remains controversial in the absence of a gold standard; however, the adverse clinical events, whether labeled as IRIS or not, appear to be common in this multicentered prospective study. We believe these results are generalizable to other sub-Saharan pediatric populations presenting with advanced AIDS. The clinical implication is that pediatric HIV providers need to be aware of the frequent unmasking of subclinical and previously latent opportunistic infections within the first few months of initiating ART.
The design of the study was cross-sectional, thus IRIS events occurring prior to or after the study visit were not included. As such, the total incidence of IRIS cannot be estimated. A future prospective pediatric cohort study is needed in sub-Saharan Africa to better inform pediatric HIV care. Extrapolating solely from adult cohort studies on the incidence, risk factors, and pathogenesis of IRIS is unwise and may lead to incorrect assumptions regarding pediatric HIV-infected populations.
Conclusion
First, the prevalence of pediatric unmasking IRIS in this study was high and is likely to continue for the foreseeable future in the resource-limited countries as long as HIV maternal-to-child-transmission (MTCT) continues unabated coupled with children presenting late for HIV care with unknown, advanced immunosuppression. Second, there is need for rapid and early pediatric HIV diagnosis so as to facilitate early ART initiation in order to minimize the HIV-related morbidity and mortality [30] , to which in part IRIS contributes. Third, there is need to re-emphasis vigorous TB screening to minimize unmasking of ART-associated TB, as this was the most common unmasked clinical infection. Fourth, providers should be aware of the frequent unmasking of subclinical infections in the first few months of ART and counsel caregivers. Finally, improved implementation of MTCT services is needed as a public health strategy to prevent IRIS through eradication of pediatric HIV.
